Sotalol Hydrochloride Tablet
Product Images NDC 0093-1061

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 0093-1061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

A line graph showing the relationship between Age (in months) on the x-axis and Age Factor on the y-axis, ranging from 0.0 to 1.0. The curve increases steadily from approximately 0.2 at 0.1 months to 1.0 at around 24 months, illustrating that the Age Factor reaches 1 for ages greater than 24 months.*

FDA Label Image

Image 2

Chemical structure of Sotalol Hydrochloride, showing its molecular components including aromatic, hydroxyl, amine, sulfonamide groups, and hydrochloride salt.*

FDA Label Image

Image 3

A line chart titled 'P-value (Oral Sotalol vs. Placebo)' showing recurrence-free survival over time in days for oral Sotalol at 80 mg, 120 mg, 160 mg doses compared to placebo. The chart includes a log-rank p-value table for the three doses. Survival curves depict differences among the treatment groups over a 360-day period.*

FDA Label Image

Image 4

A Kaplan-Meier survival curve comparing recurrence-free survival over time (in days) between oral Sotalol Hydrochloride and placebo groups. The graph shows higher recurrence-free survival for the Sotalol Hydrochloride group versus placebo, with a significant p-value (0.002) from a log-rank test.*

FDA Label Image

Image 5

Sotalol Hydrochloride Tablets USP 80 mg oral tablets label, containing 100 tablets, labeled for prescription use only. The label includes storage instructions, manufacturer information (Teva Pharmaceuticals USA, Inc.), and states it is manufactured in the Czech Republic by Teva CZ, a.s. The product NDC is 0093-1061-01.*

FDA Label Image

Image 6

Label for Sotalol Hydrochloride Tablets USP 120 mg by Teva Pharmaceuticals USA, Inc. The label states the medicine is prescription-only, contains 100 tablets, and includes storage and dosage instructions along with manufacturer details. The label features the NDC 0093-1060-01 and a barcode.*

FDA Label Image

Image 7

Sotalol Hydrochloride Tablets USP 160 mg oral tablets label, showing a 100-tablet package by Teva Pharmaceuticals USA, Inc. The label includes NDC 0093-1062-01 and detailed storage and dispensing information. The strength 160 mg is highlighted in green.*

FDA Label Image

Image 8

Sotalol Hydrochloride Tablets USP 240 mg oral tablets label from Teva Pharmaceuticals USA, Inc. The label includes NDC 0093-1063-01 and indicates the package contains 100 tablets. Storage instructions and dispensing information are visible, along with a lot/expiration area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.